Cite

HARVARD Citation

    Ribas, A. et al. (n.d.). P0116 Updated clinical efficacy of the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in 411 patients with melanoma. European journal of cancer. pp. e24-. [Online]. 
  
Back to record